Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127742962 | 12774296 | 2 | F | 201603 | 20160922 | 20160923 | 20160926 | PER | US-PFIZER INC-2016442972 | PFIZER | 65.00 | YR | F | Y | 63.50000 | KG | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127742962 | 12774296 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 50 MG, DAILY, ONE A DAY | U | N40177 | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | ||||||
| 127742962 | 12774296 | 2 | C | CALCIUM | CALCIUM | 1 | 1000 MG, DAILY | 0 | 1000 | MG | |||||||||
| 127742962 | 12774296 | 3 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 400 (UNITS UNSPECIFIED), DAILY | 0 | |||||||||||
| 127742962 | 12774296 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 1000 MG, 2X/DAY, 1,000 MG IN THE MORNING AND 1,000MG IN THE EVENING | 0 | 1000 | MG | BID | ||||||||
| 127742962 | 12774296 | 5 | C | XANAX | ALPRAZOLAM | 1 | ^50 MG^, 2X/DAY, IN THE MORNING AND AT NIGHT | 0 | BID | ||||||||||
| 127742962 | 12774296 | 6 | C | XANAX | ALPRAZOLAM | 1 | 50 MG, 2X/DAY (IN THE MORNING AND AT NIGHT) | 0 | 50 | MG | BID | ||||||||
| 127742962 | 12774296 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | QD | ||||||||
| 127742962 | 12774296 | 8 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 30 MG, DAILY, IN THE EVENING | 0 | 30 | MG | |||||||||
| 127742962 | 12774296 | 9 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 | ||||||||||||
| 127742962 | 12774296 | 10 | C | LISINOPRIL. | LISINOPRIL | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127742962 | 12774296 | 1 | Depression |
| 127742962 | 12774296 | 4 | Diabetes mellitus |
| 127742962 | 12774296 | 5 | Anxiety |
| 127742962 | 12774296 | 7 | Blood triglycerides increased |
| 127742962 | 12774296 | 8 | Depression |
| 127742962 | 12774296 | 9 | Sleep disorder |
| 127742962 | 12774296 | 10 | Blood pressure abnormal |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127742962 | 12774296 | Anxiety | |
| 127742962 | 12774296 | Drug ineffective | |
| 127742962 | 12774296 | Frustration tolerance decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127742962 | 12774296 | 1 | 201603 | 0 |